Endoscopic endonasal approach for sinonasal and anterior skull base malignancies in the elderly by Lepera, Davide et al.
OR I G I N AL ART I C L E
Endoscopic endonasal approach for sinonasal and anterior skull
base malignancies in the elderly
Davide Lepera MD1 | Federico Leone MD1 | Luca Volpi MD1 |
Maurizio Bignami MD1 | Apostolos Karligkiotis MD1 | Alessia Lambertoni MD1 |
Andrea Pistochini MD1 | Remo Accorona MD2 | Piero Nicolai MD2 |
Paolo Castelnuovo MD1
1Department of Otorhinolaryngology,
Ospedale di Circolo e Fondazione Macchi,
University of Insubria, Varese, Italy
2Department of Otorhinolaryngology,
Spedali Civili, University of Brescia,
Brescia, Italy
Correspondence
Davide Lepera, Department of
Otorhinolaryngology, University of




Background: The purpose of this study was to report the outcomes of endoscopic
transnasal resection for sinonasal and anterior skull-base cancers in elderly patients.
Methods: A retrospective review was performed. The patients were divided into 2
groups, <70 years old and 70 years old and compared by univariate analysis. Prog-
nostic factors were evaluated with a multivariate analysis. Survival rates were also
calculated.
Results: Two hundred three elderly patients and 397 younger patients were enrolled
in this study. The elderly patients reported lower survival rates than the younger
patients. When melanoma and esthesioneuroblastoma were censored, the disease-
specific survival (DSS) and recurrence-free survival (RFS) were similar. Complica-
tion rates were 17.5% without any statistical significance between the groups.
Multivariate analysis revealed that histology, stage, surgical margins, and surgical
approaches were independent predictors of survival in elderly patients.
Conclusion: The endoscopic transnasal approach reported low mortality and morbid-
ity rates also in geriatric patients, and age itself is not to be considered as a
contraindication.
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1 | INTRODUCTION
Sinonasal cancers are rare tumors, accounting for 0.5 to 1
new cases/100 000 inhabitants,1 with a high variability in
terms of histology and biological behavior. Historically,
these tumors were related with an extremely poor prognosis
due to the local aggressiveness, delayed diagnosis, contiguity
with vital structures, high morbidity of skull base surgery,
and inability to achieve a free-margin resection.2 Craniofacial
approaches, introduced in the 1960s by Ketcham et al,3 were
a major advance in the management of sinonasal cancers,
with considerable improvement in the local control of tumors
invading the anterior skull base.4 Despite the improvement in
technical skills and perioperative management, this proce-
dure is still associated with a high rate of complications and
mortality5 due to the prolonged anesthesia, the use of free tis-
sue transfer, and the significant manipulation of the brain.
Elderly patients have a reduced capability to tolerate such
important systemic and local insult, with a very poor out-
come and a significant increase in postoperative morbidity
and mortality.6 Recently, the endoscopic endonasal resection
techniques in well-selected cases and with appropriate use of
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adjuvant or neoadjuvant treatment have shown encouraging
overall survival (OS) and disease-specific survival (DSS)
rates with decreased postoperative sequelae.7 The possibility
to achieve a radical resection of the tumor with a minimal
manipulation of the brain, osteotomies, bleeding, and surgi-
cal duration is of the utmost importance in the elderly and
could be associated with a more favorable outcome in this
particular subgroup of patients. The purpose of this study
was to present the outcomes of endoscopic transnasal surgery
for sinonasal malignant tumors in elderly patients (70 years
old); to the best of our knowledge, there are no studies in the
literature focusing on this topic.
2 | PATIENTS AND METHODS
The study foresaw a retrospective review of the patients
treated for a sinonasal and/or anterior skull base malignant
tumor in 2 tertiary referral centers from June 1995 to January
2016. All the relative clinical, surgical, pathological, and
radiological data were retrieved. We retrospectively reviewed
data on patient characteristics (sex, symptoms, comorbidities,
and previous treatments), tumor features (histology, staging,
and site of origin), surgical approaches, and skull base recon-
structions, adjuvant and neoadjuvant treatments (chemother-
apy and/or radiotherapy), resection margins, and follow-up.
Patients with incomplete medical records were excluded. The
tumors were retrospectively classified according to the World
Health Organization International Histological Classification
of Tumors8 and were staged according to the Union for Inter-
national Cancer Control TNM Classification of Malignant
Tumors.9
The patients enrolled were divided according to their age
into 2 groups: <70 years old and 70 years old. The 2
groups were compared with univariate analysis by using
Fisher exact tests or chi-square tests. The variables that we
considered were histology, sex, comorbidities, stage of dis-
ease, subsites involved, symptoms, adjuvant treatment, intra-
operative and postoperative complications, and analysis on
surgical margins. The comorbidities considered in our survey
were vascular diseases, cardiac diseases, diabetes mellitus,
chronic obstructive pulmonary disease, arterial hypertension,
and chronic renal failure. Complications were categorized as
either major or minor. Minor complications were defined as
being of mild severity and self-resolving without the need
for further treatment or prolonging the hospital stay; major
ones included life-threatening complications requiring medi-
cal or surgical treatment, such as cerebrospinal fluid (CSF-l)
leaks, meningitis, massive epistaxis, pneumocephalus, pul-
monary embolism, sepsis, myocardial infarction and stroke,
or complications determining a loss of functions, such as
amaurosis and diplopia. We also classified complications
into local complications (infection, epistaxis, and hematoma),
central nervous system complications (meningitis and pneu-
mocephalus), and systemic complications (myocardial infarc-
tion, ictus, and metabolic complications).
All data were collected and processed with a commer-
cially available computer software package (SPSS for Win-
dows, version 19, 2010; SPSS, Chicago, IL). The estimated
distribution of the OS, DSS, and recurrence-free survival
(RFS) were calculated using the Kaplan-Meier method. Sex,
age, histology, surgical approaches, margins of resection,
and comorbidities were evaluated by multivariate analysis of
survival in the elderly patients, which were carried out using
an explorative Cox proportional hazard model (P values <
.05 were considered significant).
3 | RESULTS
Six hundred three patients (603) were enrolled in this survey;
206 patients aged 70 years were compared with 397
patients younger than 70 years old.
Patients, tumor features, treatment, and postoperative
data, including the univariate analysis are summarized in
Tables 1 and 2. A statistically significant difference between
the younger and the elderly patients is evident in the distribu-
tion of histologies, comorbidities, and adjuvant treatments.
Intestinal-type adenocarcinoma (ITAC) was the most repre-
sented histological type (in 23.9% of the younger and 42.2%
of the elderly patients) followed by melanoma in the elderly
(16.5%) and esthesioneuroblastoma in the younger patients
(14.9%). The univariate analysis showed a significant differ-
ence in the histological distribution between the 2 groups (P
5 .001), mostly related with ITAC, melanoma, and esthesio-
neuroblastoma. The elderly patients presented with more
comorbidities (59.7% vs 46.9%; P 5 .003). Younger patients
received more frequent adjuvant treatments (56.7% vs 46.1%;
P 5 .014). In particular, radiotherapy and chemotherapy were
administered to 54.4% and 10.1% of the younger group,
respectively, and to 37.4% and 14.1% of the elderly patients.
The univariate analysis revealed that sex, symptoms,
stage of disease, subsite involvement, surgical treatments,
and surgical margins had the same distribution between
younger and elderly patients. In the younger and elderly
patient groups, the men were 65.5% and 71.4%, respectively,
whereas the women were 34.5% and 28.6% with a male/
female ratio of 1.9/2.5 (P 5 .145). Nasal obstruction, epis-
taxis, and anosmia were the symptoms most reported in both
groups (69.5%, 45.3%, and 34.3% in the younger group, and
65.0%, 54.4%, and 27.7% in the elderly group, respectively;
P 5 .057). The tumors were staged for the younger and
elderly patients, respectively, as pT1 in 16.6% and 17.0%;
pT2 in 19.4% and 21.4%; pT3 in 21.4% and 23.3%; pT4a in
17.4% and 11.6%; and pT4b in 25.2% and 26.7% (P 5
.478). Neck lymph nodes (P 5 .951) and distant metastases
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TABLE 1 Univariate analysis of patient and tumor characteristics
No. of patients % of patients
Younger Elderly Total Younger Elderly Univariate
Histology
Adenocarcinoma ITAC 95 87 182 23.93 42.23 a
Adenocarcinoma non-ITAC 27 23 50 6.80 11.17
SCC 54 22 76 13.60 10.68
Adenoid cystic carcinoma 32 5 37 8.06 2.43
Esthesioneuroblastoma 59 5 64 14.86 2.43 a
Melanoma 22 34 56 5.54 16.50 a
Sarcoma 27 5 32 6.80 2.43
SNUC 15 5 20 3.78 2.43
SNEC 11 4 15 2.77 1.94
HPC 14 7 21 3.53 3.40
Others 41 9 50 10.33 4.37 a
Total 397 206 603 100 100 P 5 .001b
Sex
Male 260 147 407 65.49 71.36
Female 137 59 196 34.51 28.64 P 5 .145
Comorbidities
Yes 186 123 309 46.85 59.71
No 211 83 294 53.15 40.29 P 5 .003b
pT classification
pT1 66 35 101 16.62 16.99
pT2 77 44 121 19.40 21.36
pT3 85 48 133 21.41 23.30
pT4a 69 24 93 17.38 11.65
pT4b 100 55 155 25.19 26.70 P 5 .478
N classification
N0 389 202 591 97.98 98.06
N-positive 8 4 12 2.02 1.94 P 5 .951
M classification
M0 394 201 595 99.24 97.57
M-positive 3 5 8 0.76 2.43 P 5 .089
Subsites
Septum 132 85 217 33.25 41.26
Inferior turbinate 49 30 79 12.34 14.56
Ethmoid 324 171 495 81.61 83.01
Maxillary 97 39 136 24.43 18.93
Frontal 44 16 60 11.08 7.77
Sphenoid 77 41 118 19.40 19.90
Nasopharynx 32 14 46 8.06 6.80
PPF/pterygoid 39 9 48 9.82 4.37
Lacrimal pathways 16 6 22 4.03 2.91
Periorbit 43 19 62 10.83 9.22
Skull base 127 70 197 31.99 33.98
Dura 68 42 110 17.13 20.39
Brain 9 5 14 2.27 2.43 P 5 .338
(Continues)
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(P 5 .089) were evident in 2.0% and 0.8% of the younger
patients, respectively, and in 1.9% and 2.4% of the elderly
patients. In both groups, the most frequently involved sub-
sites were the ethmoid sinus (81.6% in the younger patients
and 83.0% in the elderly patients) followed by the septum
(33.3% and 41.3%, respectively), and the skull base (32.0%
and 34.0%, respectively) with no statistical significant differ-
ences between the 2 groups (P 5 .338). In the younger and
elderly patient groups, an endoscopic endonasal resection
without craniectomy was performed in 41.6% and 45.1%
TABLE 1 (Continued)
No. of patients % of patients
Younger Elderly Total Younger Elderly Univariate
Symptoms
Asymptomatic 39 16 55 9.82 7.77
Obstruction 276 134 410 69.52 65.05
Rhinorrhea 93 37 130 23.43 17.96
Epistaxis 180 112 292 45.34 54.37
Anosmia 136 57 193 34.26 27.67
Headaches 66 22 88 16.62 10.68
Facial pain 24 14 38 6.05 6.80
Visual loss 11 1 12 2.77 0.49
Epiphora 22 16 38 5.54 7.77
Diplopia 6 8 14 1.51 3.88
Swelling 8 3 11 2.02 1.46 P 5 .057
Abbreviations: HPC, hemangiopericytoma; ITAC, intestinal-type adenocarcinoma; PPF, pterygopalatine fossa; SCC, squamous cell carcinoma; SNEC, sinonasal neu-
roendocrine carcinoma; SNUC, sinonasal undifferentiated carcinoma.
aIndicates the most relevant differences.
bSignificant P value.
TABLE 2 Univariate analysis of treatment and postoperative data
No. of patients % of patients
Younger Elderly Total Younger Elderly Univariate
Surgical treatment
Endoscopic resection without craniectomy 165 93 258 41.56 45.15
Endoscopic resection with transnasal craniectomy 178 90 268 44.84 43.69
Combined transcranial-transnasal resection 54 23 77 13.60 11.17 P 5 .583
Adjuvant treatment
Total 225 95 320 56.68 46.12
RT 216 77 293 54.41 37.38
Chemotherapy 40 29 69 10.08 14.08 P 5 .014a
Complications
Total 65 41 106 16.37 19.90 P 5 .280
Major 26 19 45 6.55 9.22
Minor 39 22 61 9.82 10.68 P 5 .668
CNS 27 19 46 6.80 9.22
Systemic 15 8 23 3.78 3.88
Local 23 14 37 5.79 6.80 P 5 .280
Margins
Positives 42 26 68 10.58 12.62
Negatives 355 180 535 89.42 87.38 P 5 .565
Abbreviations: CNS, central nervous system; RT, radiotherapy.
aSignificant P value.
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cases, respectively, endoscopic resection with transnasal cra-
niectomy in 44.8% and 43.7% cases, and a combined
transcranial-transnasal resection in 13.6% and 11.2% (P 5
.583).
Complications were reported in 17.5% of the population
enrolled. In the elderly group, the complication rate was
19.9% and, although this was higher than in the younger
group (16.4%), there was no statistical significant difference
(P 5 .280). Overall, postoperative mortality was 0.33% (2
cases of blowout of internal carotid artery with exitus in the
younger patient group and no cases in the elderly patient
group). Positive surgical margins were reported in 68 cases
(11.3%), 10.7% and 12.6% in the young and elderly patient
groups, respectively (P 5 .565). Melanoma and adenoid
cystic carcinoma have high rates of positive surgical margins
due to their biological behavior and local aggressiveness.
When melanoma and adenoid cystic carcinoma were cen-
sored, positive surgical margins were reported in 8.0% of the
selected population.
The median follow-up was 57 months (range 6-224
months). Five-year and 10-year OS, DSS, and RFS rates for
the elderly patients were significantly poorer than for patients
aged <70 years. The 5-year OS was 66.3% 6 4.03% vs
81.9% 6 2.24%, and 10-year OS was 52.8% 6 5.75% vs
71.8% 6 3.27%; P 5 .0003. The 5-year DSS was 75.2% 6
3.79% vs 85.0% 6 2.09%, and the 10-year DSS was 69.3%
6 5.13% vs 78.3% 6 2.25%; P 5 .0454. The 5-year RFS
was 66.2% 6 4.07% vs 75.4% 6 2.49%, and the 10-year
RFS was 58.4% 6 4.97% vs 68.8% 6 3.08%; P 5 .0369)
Figure 1. When censored for melanoma and esthesioneuro-
blastoma, only the 5-year and 10-year OS between elderly
and younger patients were very close to statistical signifi-
cance (P 5 .054), whereas the DSS and RFS were no more
statistically significant (P 5 .915 and .179, respectively) Fig-
ure 2. The 5-year and 10-year OS and DSS of elderly
patients with positive surgical margins were comparable with
the younger patients and poorer when compared with the
elderly patients with negative surgical margins. The survival
curves showed moreover that the elderly patients reported a
worst survival in local advanced disease (pT3-4) when com-
pared to early disease (pT1-2). The results of the survival
curves are summarized in Table 3.
When elderly patients were stratified according to the
presence (59.7%) or absence (40.3%) of comorbidities, the
OS, DSS, and RFS were not statistically different between
the 2 subgroups (Figure 3 and Table 3). Elderly patients with
comorbidities reported an increased rate of postoperative
complications (20.2%) compared with elderly patients with-
out comorbidities (18.6%). However, no statistical signifi-
cance was found (P 5 .67).
FIGURE 1 A,Overall survival, B, disease-specific survival, and C, recurrence-free survival are illustrated for patients with malignant tumors of para-
nasal sinuses or anterior skull base stratified by age [Color figure can be viewed at wileyonlinelibrary.com]
FIGURE 2 A,Overall survival, B, disease-specific survival, and C, recurrence-free survival are illustrated (with melanoma and esthesioneuroblas-
toma censored) for patients withmalignant tumors of paranasal sinuses or anterior skull base stratified by age [Color figure can be viewed at wileyonline-
library.com]
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The multivariate analysis in elderly patients reported that
pT (T1-2 vs T3-4), histology (esthesioneuroblastoma, adeno-
carcinoma, melanoma, the carcinoma group, and others],
margins (positive vs negative), and surgical approaches
(endonasal endoscopic resection with or without craniectomy
vs combined transcranial-transnasal resection) were inde-
pendent predictor factors for the OS and DSS, whereas pT,
histology, and surgical margins were independent predictor
factors for the RFS (Table 4).
4 | DISCUSSION
With the increase in life expectancy, the interest of many sur-
gical specialties has moved toward the elderly in terms of
extending surgical indications and improving the manage-
ment of complications. It is known that elderly patients with
cancer receive frequently nonstandard treatments.10 The fear
of severe postoperative complications in this fragile popula-
tion leads more often to inadequate surgical or nonsurgical
management.11 Over the past 3 decades, by reducing the
invasiveness of the transcranial and transfacial approaches,
the endoscopic approach has played an important role in
sinonasal and anterior skull base surgery and several authors
have published series of elderly patients surgically treated for
different sinonasal and skull base pathologies. Jiang and
Hsu12 noted that functional endoscopic sinus surgery in the
elderly population accounted for 15.6% of all endoscopic
surgeries in their population and reported a slightly increased
complication rate as compared to their adult and pediatric
group, whereas other authors have concluded that complica-
tion rates after functional endoscopic sinus surgery are not
related to age.13 Emanuelli et al14 described a complete clo-
sure of the anterior skull base CSF-l in 20 patients aged 65
years old without complications. Zhan et al15 performed a
retrospective review of 158 elderly patients (aged 65 years or
older) who underwent a purely endoscopic transsphenoidal
approach for a pituitary adenoma, comparing them with a
series of 155 younger patients with no statistically significant
differences in gross tumor removal, visual outcome, relapse,
hypopituitarism, diabetes insipidus, CSF-l, or systemic
complications.
TABLE 3 Survival rates
Survival rates (% 6 SE%) 5-y 10-y
All patients <70 70 <70 70 P value
OS 81.9 6 2.24% 66.3 6 4.03% 71.8 6 3.27% 52.8 6 5.75% .0003a
DSS 85.0 6 2.09% 75.2 6 3.79% 78.3 6 2.25% 69.3 6 5.13% .0454
RFS 75.4 6 2.49% 66.2 6 4.07% 68.8 6 3.08% 58.4 6 4.97% .369
ONB and melanoma censored
OS 80.1 6 2.59% 71.9 6 4.16% 70.3 6 3.64% 56.4 6 6.34% .054
DSS 83.8 6 2.40% 82.2 6 3.69% 78.6 6 3.09% 75.3 6 5.49% .915
RFS 78.1 6 2.63% 72.2 6 4.24% 72.6 6 3.31% 62.9 6 5.53% .179
Positive margins in all patients
OS 70.2 6 9.46% 26.3 6 14.9% 52.7 6 12.9% 26.3 6 14.9% .1657
DSS 72.2 6 9.52% 36.5 6 18.9% 54.1 6 13.2% 36.5 6 18.9% .410
Margins in elderly patients Positive Negative Positive Negative
OS 26.3 6 14.9% 69.4 6 4.26% 26.3 6 14.9% 53.3 6 6.51% .0051a
DSS 36.5 6 18.9% 78.0 6 3.91% 36.5 6 18.9% 71.1 6 5.71% .0070a
Elderly patients according to the pT pT1-2 pT3-4 pT1-2 pT3-4
OS 85.8 6 4.75% 50.9 6 5.99% 68.4 6 9.31% 38.4 6 7.99% < .0001a
DSS 96.1 6 2.72% 59.2 6 6.13% 93.0 6 4.03% 48.7 6 9.29% < .0001a
RFS 85.4 6 4.74% 49.4 6 5.83% 85.4 6 4.7% 42.3 6 8.23% < .0001a
Comorbidities in elderly patients Yes No Yes No
OS 66.5 6 4.78% 65.5 6 7.49% 49.6 6 7.16% 61.2 6 8.16% .8267
DSS 74.9 6 4.55% 76.2 6 6.68% 68.3 6 6.46% 71.1 6 7.93% .9947
RFS 66.6 6 4.86% 64.4 6 7.53% 63.1 6 5.2% 44.6 6 11.3% .2209
Abbreviations: DSS, disease-specific survival; ONB, olfactory neuroblastoma; OS, overall survival; RFS, recurrence-free survival.
aSignificant P value.
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Both increased experience in the endoscopic manage-
ment of inflammatory disease, benign tumors, and CSF-l,
and the advances in instrumentation, surgical navigation, and
skull-base reconstruction, have allowed endoscopic surgery
to emerge as a minimally invasive alternative to open
approaches during the past decades for sinus and skull base
malignancies. This process has been controversial,16–19 in
particular due to the nonconformity with the oncologic
principles of “en bloc” resection. With the transnasal endo-
scopic approach, free-margin resection is rather achieved
through a progressive disassembling of the lesion with a
“centripetal” resection. The first step is the debulking of the
tumor, followed by a subperiosteal/subperichondrial dissec-
tion of the nasoethmoidal complex, including if required the
septum and/or contralateral nasoethmoidal complex; the
resection could be progressively enlarged superiorly to
FIGURE 3 A,Overall survival, B, disease-specific survival, and C, recurrence-free survival are illustrated only for elderly patients (aged 70 or more)
withmalignant tumors of paranasal sinuses or anterior skull base stratified by comorbidities (With: with comorbidities;Without: without comorbidities)
[Color figure can be viewed at wileyonlinelibrary.com]





Sex, M vs F 3 (1.5-6.3) .09
pT1-T2 vs pT3-T4 2.02 (0.97-4.2) .038a
Histology (esthesioneuroblastoma, adenocarcinoma, carcinoma group, melanoma, and others) 1.6 (1.2-2.1) < .065a
Surgical margins 2.3 (1.3-4.5) .007a
Endonasal endoscopic resection with or without craniectomy vs combined
transcranial-transnasal resection
3.5 (1.5-8.1) .022a
Medical comorbidities 0.6 (0.3-1.1) .12
DSS
Sex, M vs F 3 (1.5-6.8) .06
pT1-T2 vs pT3-T4 7.1 (1.6-9.2) .009a
Histology (esthesioneuroblastoma, adenocarcinoma, carcinoma group, melanoma, and others) 1.8 (1.3-2.5) < .048a
Surgical margins 2.1 (1.3-4.5) .006a
Endonasal endoscopic resection with or without craniectomy vs combined
transcranial-transnasal resection
3 (0.96-9.1) .048a
Medical comorbidities 0.6 (0.3-1.5) .132
RFS
Sex, M vs F 1.9 (0.9-5.5) .13
pT1-T2 vs pT3-T4 5.7 (1.9-12.2) < .016a
Histology (esthesioneuroblastoma, adenocarcinoma, carcinoma group, melanoma, and others) 1.5 (1.2-2) .006a
Surgical margins 2.1 (0.9-4.2) .035a
Endonasal endoscopic resection with or without craniectomy vs combined
transcranial-transnasal resection
2.1 (0.7-6.6) .18
Abbreviations: CI, confidence interval; DSS, disease-specific survival; OS, overall survival; RFS, recurrence-free survival.
aSignificant P value.
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include the ethmoidal roof, the dura mater, the olfactory
bulbs, and laterally to include the medial wall of the maxil-
lary sinus with the lacrimal pathways, the papyracea, and the
periorbit.20 During the last 20 years, endoscopic resection
has achieved a general consensus in selected patients pro-
gressively clarifying and expanding the indications.21 In a
recent meta-analysis, Rawal et al22 reported that the 2-year
and 5-year OS rates of 759 patients treated with endoscopic
endonasal resection for sinonasal malignancies (85.8% and
83.5%, respectively) were comparable or even better than the
rates reported for open craniofacial resections. Thus, cur-
rently, endoscopic and open approaches should not be con-
sidered in contrast to each other but should be carefully
selected in every case23 in order to achieve a radical resection
of the tumor. However, the eligibility for craniofacial resec-
tion in elderly patients is critical due to the increased periop-
erative morbidity and mortality6 rates encountered. The
elderly are usually classified into young-old (65-75 years),
old-old (76-85 years), and oldest-old groups (>85 years)24
according to the classification adopted by the National Insti-
tute on Aging and the National Institutes of Health. How-
ever, most clinical studies use as a cutoff the age of 70 years
to define elderly patients.25 Unfortunately, no universally
accepted criteria exist that would facilitate clinical decision
making and we adopted 70 years old as our cutoff to obtain
results comparable with most studies in literature.
At present, all recommendations for management of
elderly patients diagnosed with head and neck cancer are
based on retrospective studies or subset analyses of prospec-
tive trials. Concerning head and neck cancers, most studies
report that extensive surgical treatment (such as laryngecto-
mies, neck dissections, and myocutaneous flap reconstruc-
tions) was not related with an increased rate of mortality and
was associated with acceptable incidences of complica-
tions.26,27 Consequently, we can assume that elderly patients
with head and neck cancer may be eligible, with proper
selection, for extensive surgical treatment.28 However, sino-
nasal and anterior skull base tumors are a particular subgroup
of head and neck cancers and should be considered inde-
pendently; currently, there are no pertinent studies analyzing
this subgroup of patients considering the advent of the endo-
scopic approaches. In literature, there are 3 studies reporting
the results of craniofacial surgery in elderly patients,6,29,30
whereas not one concerning the endoscopic transnasal
approach for sinonasal malignancies could be found.
Our study includes a large sample of patients from 2 Ital-
ian tertiary centers with the same policy in terms of diagnos-
tic and therapeutic management of sinonasal cancers. The
uniformity of the sample is the strength of this study,
although it is a retrospective analysis and it is consequently
susceptible to the shortcomings in data collection that are
possible in such study designs.
In our analysis, elderly patients showed lower 5-year and
10-year OS (66.3% and 52.8%), DSS (75.2% and 69.3%),
and RFS (66.2% and 58.4%) when compared with patients
aged <70 (Figure 1 and Table 3). Worst outcomes in elderly
patients are demonstrated also in cases of craniofacial sur-
gery in patients aged 70 years or more with 3-year OS of
53%6 and 5-year OS of 42%,29,30 which are poorer when
compared to the present series.
In the present study, no statistically significant differen-
ces were found between the young and the elderly patients
regarding the TNM classification distribution, also in terms
of subsite involvement. The criteria for resectability, which
is beyond the intent of our article and is detailed elsewhere,31
were applied always regardless of the age of the patients.
Because there were no differences in the surgical indications
and in subsite involvement, as expected, we found no statisti-
cally significant differences between the 2 groups concerning
the surgical approaches: endoscopic resection without crani-
ectomy and endoscopic resection with transnasal craniec-
tomy or combined transcranial-transnasal resection. Hence,
the compared groups are similar in terms of disease and treat-
ment, thus excluding a potential selection bias in our survey
(Tables 1 and 2).
The International Collaborative Study (ICS) group
reported that 4 factors were independent predictors of sur-
vival outcome of sinonasal malignant tumor32: histology,
medical comorbidity, intracranial involvement, and surgical
margins. Because of the great variability in the biological
behavior, the histology is the main feature for the prognosis
of anterior skull base cancers and, in fact, a significant differ-
ence in the distribution of the histotypes was evident in our
univariate analysis (Tables 1 and 2). Melanoma is a highly
aggressive tumor with a poor prognosis (5-year OS 6.5%-
34%33) and a higher prevalence in elderly people,34 as
reported in our data: 16.5% and 6.0%, respectively. Con-
versely, younger patients are more affected by esthesioneuro-
blastoma (16.0% and 2.4%, respectively), which is related
with a relatively more favorable prognosis among the sino-
nasal cancers.35 When melanoma and esthesioneuroblastoma
were censored, the elderly patients presented worse 5-year
and 10-year OS rates (71.9% and 56.4%, respectively) com-
pared to the group of the younger patients (80.1% and
70.3%, respectively) with a P 5 .05 (Figure 2 and Table 3).
On the other hand, there were no statistically significant dif-
ferences when we considered the DSS and RFS (P 5 .92
and .18, respectively). This confirms that the biological
behavior and distribution of the different histologies have a
prominent role in determining the worst prognosis in the
elderly patients.
The multivariate analysis (Table 4) demonstrated that his-
tology, stage of disease, and surgical margins were independ-
ent predictors of survival outcome in the elderly patients.
Medical comorbidities were not associated with a worse
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outcome, as previously reported, probably due to different
factors, such as better perioperative management, more accu-
rate selection of the patients, and the reduced morbidity of
the endoscopic approach. Moreover, the Kaplan-Meier test in
our analysis failed to reach a statically significant difference
between elderly patients with and those without comorbid-
ities (Figure 3 and Table 3), whereas comorbidities have
been related with a worse prognosis in craniofacial
surgery.29
The survival rates in elderly patients reported in our anal-
ysis show a dramatic decrease of the OS and DSS for local
advanced disease (pT1-2 compared with pT3-4) and positive
surgical margins (the data are detailed in Table 3). These
findings are confirmed by the above-mentioned multivariate
analyses.
A study on 1201 patients treated for head and neck can-
cers (including 87 sinonasal cancers) reports that age did not
significantly predict complications and the risk of complica-
tions was significantly related to sex, comorbidity, stage,
type of surgery, violation of the aerodigestive tract, recon-
struction type, neck dissection, and length of intervention;
the last one was found to be one of the most important pre-
dictors of surgical and nonsurgical complications.27 In our
survey, we reported complications in 17.5% of the 603
patients enrolled. Considering the elderly patients, the rate of
overall complications was 19.9%, with 10.7% of minor ones.
However, there were no significant differences compared
with the younger patients (16.4%; P 5 .280). Craniofacial
resections are generally related with 25%-65% of complica-
tions36 with a 4.7% of perioperative mortality.32 Considering
the elderly patients, the reported complications of craniofa-
cial resections range from 42% to 64%, and the mortality
from 4% to 17%.6,29,30 Although the endoscopic and cranio-
facial approaches have different indications and the results
presented by the different studies cannot be directly com-
pared, it should be highlighted that the endoscopic approach
has encouraging low complications rates in elderly patients.
5 | CONCLUSION
Advanced age, per se, should not be considered a contraindi-
cation to adequate surgical treatment in sinonasal and anterior
skull base cancers. Other factors, including comorbidities, dis-
abilities, frailty, and impaired functional status, must be eval-
uated and represent more relevant criteria than chronological
age by itself for decision making. Thus, a comprehensive
geriatric assessment along with a multidisciplinary approach
is mandatory. Endoscopic endonasal resection is safe and
effective also in elderly patients and, when correctly indi-
cated, it should be preferred to open craniofacial resection
due to the lower perioperative morbidity and mortality rates
and the similar oncologic outcomes. Compared to the
younger patients, the elderly patients in our study presented
more aggressive histologies, which are factors related with a
worse prognosis; when melanoma and esthesioneuroblastoma
data were censored, the DSS and RFS proved to be similar in
both the young and the elderly patients. Histology, stage of
disease, surgical margins, and surgical approaches were inde-
pendent predictors of survival outcome in the elderly patients.
DICLOSURE
This work had no specific funding, and there are no con-
flict of interest disclosures from any authors.
ORCID
Davide Lepera MD http://orcid.org/0000-0001-7646-2242
Apostolos Karligkiotis MD http://orcid.org/0000-0003-
0129-9908
REFERENCES
[1] Magnani C, Ciambellotti E, Salvi U, Zanetti R, Comba P. [The
incidence of tumors of the nasal cavity and the paranasal sinuses
in the district of Biella, 1970-1986]. Acta Otorhinolaryngol Ital.
1989;9(5):511-519.
[2] Frazell EL, Lewis JS. Cancer of the nasal cavity and accessory
sinuses. A report of the management of 416 patients. Cancer.
1963;16:1293-1301.
[3] Ketcham AS, Wilkins RH, Vanburen JM, Smith RR. A com-
bined intracranial facial approach to the paranasal sinuses. Am J
Surg. 1963;106:698-703.
[4] Lund VJ, Harrison DF. Craniofacial resection for tumors of the
nasal cavity and paranasal sinuses. Am J Surg. 1988;156(3 Pt
1):187-190.
[5] Gil Z, Patel SG, Bilsky M, Shah JP, Kraus DH. Complications
after craniofacial resection for malignant tumors: are complica-
tion trends changing? Otolaryngol Head Neck Surg. 2009;140
(2):218-223.
[6] Ganly I, Gross ND, Patel SG, Bilsky MH, Shah JP, Kraus DH.
Outcome of craniofacial resection in patients 70 years of age
and older. Head Neck. 2007;29(2):89-94.
[7] Castelnuovo P, Battaglia P, Turri-Zanoni M, et al. Endoscopic
endonasal surgery for malignancies of the anterior cranial base.
World Neurosurg. 2014;82(6 Suppl):S22-S31.
[8] El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ.
WHO Classification of Head and Neck Tumours. International
Agency for Research on Cancer 2017.
[9] Brierley JD, Gospodarowicz MK, Wittekind C. TNM Classifica-
tion of Malignant Tumours. Wiley, 2016.
[10] Sarini J, Fournier C, Lefebvre JL, Bonafos G, Van JT, Coche-
Dequeant B. Head and neck squamous cell carcinoma in elderly
patients: a long-term retrospective review of 273 cases. Arch
Otolaryngol Head Neck Surg. 2001;127(9):1089-1092.
[11] Datema FR, Ferrier MB, van der Schroeff MP, Baatenburg de
Jong RJ. Impact of comorbidity on short-term mortality and
LEPERA ET AL. | 9
overall survival of head and neck cancer patients. Head Neck.
2010;32(6):728-736.
[12] Jiang RS, Hsu CY. Endoscopic sinus surgery for the treatment
of chronic sinusitis in geriatric patients. Ear Nose Throat J.
2001;80(4):230-232.
[13] Colclasure JC, Gross CW, Kountakis SE. Endoscopic sinus sur-
gery in patients older than sixty. Otolaryngol Head Neck Surg.
2004;131(6):946-949.
[14] Emanuelli E, Milanese L, Rossetto M, et al. The endoscopic
endonasal approach for cerebrospinal fluid leak repair in the
elderly. Clin Neurol Neurosurg. 2015;132:21-25.
[15] Zhan R, Ma Z, Wang D, Li X. Pure endoscopic endonasal trans-
sphenoidal approach for nonfunctioning pituitary adenomas in
the elderly: surgical outcomes and complications in 158 patients.
World Neurosurg. 2015;84(6):1572-1578.
[16] Banhiran W, Casiano RR. Endoscopic sinus surgery for benign
and malignant nasal and sinus neoplasm. Curr Opin Otolaryngol
Head Neck Surg. 2005;13(1):50-54.
[17] Stammberger H, Anderhuber W, Walch C, Papaefthymiou G.
Possibilities and limitations of endoscopic management of nasal
and paranasal sinus malignancies. Acta Otorhinolaryngol Belg.
1999;53(3):199-205.
[18] Lund V, Howard DJ, Wei WI. Endoscopic resection of malignant
tumors of the nose and sinuses. Am J Rhinol. 2007;21(1):89-94.
[19] Samant S, Kruger E. Cancer of the paranasal sinuses. Curr
Oncol Rep. 2007;9(2):147-151.
[20] Nicolai P, Castelnuovo P, Bolzoni Villaret A. Endoscopic resection
of sinonasal malignancies. Curr Oncol Rep. 2011;13(2):138-144.
[21] Suh JD, Ramakrishnan VR, Chi JJ, Palmer JN, Chiu AG. Out-
comes and complications of endoscopic approaches for malig-
nancies of the paranasal sinuses and anterior skull base. Ann
Otol Rhinol Laryngol. 2013;122(1):54-59.
[22] Rawal RB, Farzal Z, Federspiel JJ, Sreenath SB, Thorp BD,
Zanation AM. Endoscopic resection of sinonasal malignancy: a
systematic review and meta-analysis. Otolaryngol Head Neck
Surg. 2016;155(3):376-386.
[23] Lepera D, Volpi L, Facco C, et al. Endoscopic treatment of
Ewing sarcoma of the sinonasal tract. J Craniofac Surg. 2016;27
(4):1001-1006.
[24] Balducci L. Management of cancer in the elderly. Oncology
(Williston Park). 2006;20(2):135-143; discussion 144, 146, 151-
152.
[25] Argiris A, Li Y, Murphy BA, Langer CJ, Forastiere AA. Out-
come of elderly patients with recurrent or metastatic head and
neck cancer treated with cisplatin-based chemotherapy. J Clin
Oncol. 2004;22(2):262-268.
[26] Spyropoulou GA, Jeng SF, Hsieh CH, Tsimponis A, Shih HS.
Microsurgical reconstruction for head and neck cancer in elderly
patients. J Reconstr Microsurg. 2014;30(2):91-96.
[27] Peters TT, van Dijk BA, Roodenburg JL, van der Laan BF, Hal-
mos GB. Relation between age, comorbidity, and complications
in patients undergoing major surgery for head and neck cancer.
Ann Surg Oncol. 2014;21(3):963-970.
[28] Teymoortash A, Ferlito A, Halmos GB. Treatment in elderly
patients with head and neck cancer: a challenging dilemma.
HNO. 2016;64(4):217-220.
[29] Ganly I, Patel SG, Singh B, et al. Craniofacial resection for
malignant tumors involving the skull base in the elderly: an
international collaborative study. Cancer. 2011;117(3):563-571.
[30] Hentschel SJ, Nader R, Suki D, Dastgir A, Callender DL,
DeMonte F. Craniofacial resections in the elderly: an outcome
study. J Neurosurg. 2004;101(6):935-943.
[31] Nicolai P, Battaglia P, Bignami M, et al. Endoscopic surgery for
malignant tumors of the sinonasal tract and adjacent skull base:
a 10-year experience. Am J Rhinol. 2008;22(3):308-316.
[32] Ganly I, Patel SG, Singh B, et al. Complications of craniofacial
resection for malignant tumors of the skull base: report of an
International Collaborative Study. Head Neck. 2005;27(6):445-
451.
[33] Lund VJ, Howard DJ, Harding L, Wei WI. Management options
and survival in malignant melanoma of the sinonasal mucosa.
Laryngoscope. 1999;109(2 Pt 1):208-211.
[34] Manolidis S, Donald PJ. Malignant mucosal melanoma of the
head and neck: review of the literature and report of 14 patients.
Cancer. 1997;80(8):1373-1386.
[35] Eden BV, Debo RF, Larner JM, et al. Esthesioneuroblastoma.
Long-term outcome and patterns of failure–the University of Vir-
ginia experience. Cancer. 1994;73(10):2556-2562.
[36] Gray ST, Lin A, Curry WT, et al. Delayed complications after
anterior craniofacial resection of malignant skull base tumors.
J Neurol Surg B Skull Base. 2014;75(2):110-116.
How to cite this article: Lepera D, Leone F, Volpi L,
et al. Endoscopic endonasal approach for sinonasal and
anterior skull base malignancies in the elderly. Head &
Neck. 2018;00:1–10. https://doi.org/10.1002/hed.25045
10 | LEPERA ET AL.
